PSIAC
Sad Pill Bild Bildrechte: © spinetta / Fotolia

Oops!

Sie verwenden eine veraltete Version Ihres Internetbrowsers und können nicht auf die Inhalte der Seite zugreifen.
Bitte aktualisieren Sie Ihre Browserversion.

PSIAC

Literaturverzeichnis

Erweiterte Suche
Crass RL. Pharmacotherapy. Feb 2019; 39(2): 182-195 Pubmed [8226]
Crauwels H, 2010. Pharmacokinetic interaction study between TMC278, a next-generation NNRTI, and methadone. Abstract WEPE0089, presented at the XVIII International AIDS Conference, July 18–23, 2010, Vienna, Austria [3412]
Crauwels H. AIDS Rev. Apr 2013; 15(2): 87-101 Pubmed [6553]
Crauwels HM. Int J Clin Pharmacol Ther. Feb 2014; 52(2): 118-28 Pubmed [6556]
Crauwels HM. J Clin Pharmacol. Feb 2014; 54(2): 133-40 Pubmed [6568]
Cravens MG. Cureus. Jan 2019; 11(1): e3827 Pubmed, Volltext, DOI [7162]
Crawford P. CNS Drugs. Jan 2002; 16(4): 263-72 Pubmed [9276]
Crettol S. Clin Pharmacol Ther. Dec 2005; 78(6): 593-604 Pubmed [1832]
Crettol S. Clin Pharmacol Ther. Dec 2006; 80(6): 668-81 Pubmed [146]
Crettol S. Curr Pharm Des. Jan 2010; 16(2): 204-19 Pubmed [5021]
Crewe HK. Biochem Pharmacol. Jan 1997; 53(2): 171-8 Pubmed [4019]
Crewe HK. Br J Clin Pharmacol. Sep 1992; 34(3): 262-5 Pubmed, Volltext [5004]
Crippin JS. Am J Gastroenterol. Apr 1993; 88(4): 590-2 Pubmed [6807]
Croissant B. Am J Drug Alcohol Abuse. Jan 2008; 34(5): 534-40 Pubmed [10641]
Crommentuyn KM. Clin Infect Dis. Apr 2004; 38(8): e73-5 Pubmed [6428]
Cronson AJ. Am J Psychiatry. Jul 1978; 135(7): 856-7 Pubmed [1681]
Cropp JS. Pharmacotherapy. Sep 1997; 17(5): 917-28 Pubmed [4758]
Cropp, J.S. Pharmacotherapy. Volume 17(Issue 5): Pages 917-928 Pubmed [9158]
Cross HM. S Afr Med J. Mar 2018; 108(4): 271-274 Pubmed [7173]
Crowe A. Toxicol Appl Pharmacol. May 2012; 260(3): 294-302 Pubmed [159]
Crowe S. Anesthesiology. Feb 2003; 98(2): 574-5 Pubmed [9849]
Crowley JJ. Clin Pharmacol Ther. Sep 1987; 42(3): 334-40 Pubmed [2734]
Crucitti A. Curr Med Res Opin. Nov 2010; 26(11): 2579-88 Pubmed [12934]
Cruddas L. J Eur Acad Dermatol Venereol. Jun 2017; 31(6): 952-963 Pubmed [6951]
Crussell-Porter LL. Arch Intern Med. Jan 1993; 153(1): 102-4 Pubmed [5892]
Cruz Rodriguez JB. Ann Transl Med. Mar 2021; 9(6): 519 Pubmed [11045]
Csajka C. Clin Pharmacokinet. Dec 2016; 55(12): 1521-1533 Pubmed [7562]
Csik V, Molnar J. Possible adverse interaction between clozapine and ampicillin in an adolescent with schizophrenia. J Child Adolesc Psychopharmacol (1994) 4, 123-8 [1108]
Csuka M. JAMA. May 1986; 255(17): 2315-9 Pubmed [8882]
Cuadrado A et al. Method Find exp Clin Pharmacol (1996) 18 (Suppl C), 65 [717]
Cuadrado A. Eur J Pharmacol. Mar 2003; 465(1-2): 43-52 Pubmed [9500]
Cuadrado A. Pharmacol Res. May 2005; 51(5): 489-96 Pubmed [9321]
Cubeddu Curr Cardiol Rev. 2009 Aug;5(3):166-76.-122 [3083]
Cubeddu LX. Am J Ther. Nov 2003; 10(6): 452-7 Pubmed [7795]
Cubeddu LX. Curr Cardiol Rev. Aug 2009; 5(3): 166-76 Pubmed [12718]
Cudmore J. Can Fam Physician. Jan 2014; 60(1): 53-6 Pubmed, Volltext [5310]
Cuesta Grueso C. Farm Hosp. May 2006; 30(3): 149-53 Pubmed [7267]
Cueva JE. J Am Acad Child Adolesc Psychiatry. Apr 1996; 35(4): 480-90 Pubmed [11701]
Cui C. Curr Drug Metab. Jan 2020; 21(6): 427-435 Pubmed [10786]
Culm-Merdek KE. Br J Clin Pharmacol. Nov 2005; 60(5): 486-93 Pubmed, Volltext, DOI [7699]
Culm-Merdek KE. Clin Pharmacol Ther. Mar 2006; 79(3): 243-54 Pubmed [11683]
Culmsee C. Stroke. May 2004; 35(5): 1197-202 Pubmed [3194]
Cummings JL. CNS Spectr. Feb 2022; 27(1): 7-15 Pubmed [14192]
Cundy KC. Clin Pharmacokinet. Feb 1999; 36(2): 127-43 Pubmed [7095]
Cuñetti L. Transplant Proc. Mar 2018; 50(2): 461-464 Pubmed [13604]
Cunningham D. Am J Emerg Med. Sep 2021 Pubmed [11127]
Cunningham RF. Clin Pharmacokinet. Mar 1981; 6(2): 135-51 Pubmed [7553]
Curis E. Infection. Aug 2015; 43(4): 473-81 Pubmed [5650]
Curran A. Expert Rev Anti Infect Ther. Dec 2011; 9(12): 1115-8 Pubmed [8748]
Curran MP. Drugs. Jan 2010; 70(2): 191-213 Pubmed [4142]
Curry ML, Curry SH, Marroum PJ. Interaction of phenothiazine and related drugs and caffeinated beverages. DICP Ann Pharmacother (1991) 25, 437-8 [857]
Curry MP. N Engl J Med. Dec 2015; 373(27): 2618-28 Pubmed [7903]
Curry SH. Br J Pharmacol. Jul 1971; 42(3): 403-11 Pubmed, Volltext [900]
Curry SH. Eur J Clin Pharmacol. Jan 1985; 29(4): 429-33 Pubmed [528]
Curry SH. Eur J Clin Pharmacol. Jan 1987; 32(3): 317-20 Pubmed [565]
Curtis BR. Immunohematology. Jan 2014; 30(2): 95-101 Pubmed [8144]
Curtis LH. Am J Med. Feb 2003; 114(2): 135-41 Pubmed [4943]
Cusato J. J Antimicrob Chemother. Jun 2018; 73(6): 1659-1664 Pubmed [7206]
Custodio J, West S, Vu A, et al., Lack of clinically relevant effect of bictegravir on metformin pharmacokinetics and pharmacodynamics. Paper presented at: 18th International Workshop on Clinical Pharmacology of Antiviral Therapy; 2017; Chicago, IL. Available from: http://www.natap.org/2017/Pharm/Pharm_32.htm. Accessed May 29, 2018. [7479]
Custodio J, West S, Vu A, et al., Lack of clinically relevant effect of bictegravir on metformin pharmacokinetics and pharmacodynamics. Paper presented at: 18th International Workshop on Clinical Pharmacology of Antiviral Therapy; 2017; Chicago, IL. Available from: http://www.natap.org/2017/Pharm/Pharm_32.htm. Accessed May 29. [7478]
Custodio J, West S, Vu A, et al., Pharmacokinetics of bictegravir administered twice daily with rifampin. Paper presented at: The Conference on Retroviruses and Opportunistic Infections (CROI); 2018; Boston, MA. Available from: http://www.croiconference.org/sessions/ pharmacokinetics-bictegravir-administered-twice-daily-combinationrifampin. Accessed May 29, 2018. [7488]
Custodio J, West S, Vu A, et al., Pharmacokinetics of bictegravir administered twice daily with rifampin. Paper presented at: The Conference on Retroviruses and Opportunistic Infections (CROI); 2018; Boston, MA. Available from: http://www.croiconference.org/sessions/ pharmacokinetics-bictegravir-administered-twice-daily-combinationrifampin. Accessed May 29, 2018. [7489]
Custodio J, West S, Vu A, et al., Pharmacokinetics of bictegravir administered twice daily with rifampin. Paper presented at: The Conference on Retroviruses and Opportunistic Infections (CROI); 2018; Boston, MA. Available from: http://www.croiconference.org/sessions/ pharmacokinetics-bictegravir-administered-twice-daily-combinationrifampin. Accessed May 29, 2018. [7490]
Custodio J, West S, Vu A, et al., Pharmacokinetics of bictegravir administered twice daily with rifampin. Paper presented at: The Conference on Retroviruses and Opportunistic Infections (CROI); 2018; Boston, MA. Available from: http://www.croiconference.org/sessions/ pharmacokinetics-bictegravir-administered-twice-daily-combinationrifampin. Accessed May 29, 2018.. [7486]
Custodio J, West S, Vu A, et al., Pharmacokinetics of bictegravir administered twice daily with rifampin. Paper presented at: The Conference on Retroviruses and Opportunistic Infections (CROI); 2018; Boston, MA. Available from: http://www.croiconference.org/sessions/ pharmacokinetics-bictegravir-administered-twice-daily-combinationrifampin. Accessed May 29, 2018.. [7487]
Custodio JM. J Clin Pharmacol. Jun 2014; 54(6): 649-56 Pubmed [6670]
Custodio JM. Pharmacol Res Perspect. Oct 2017; 5(5) Pubmed, Volltext, DOI [7437]
Custodio, West S, Vu A, et al., Pharmacokinetics of bictegravir administered twice daily with rifampin. Paper presented at: The Conference on Retroviruses and Opportunistic Infections (CROI); 2018; Boston, MA. Available from: http://www.croiconference.org/sessions/ pharmacokinetics-bictegravir-administered-twice-daily-combinationrifampin. Accessed May 29, 2018.. [7483]
Custodio, West S, Vu A, et al., Pharmacokinetics of bictegravir administered twice daily with rifampin. Paper presented at: The Conference on Retroviruses and Opportunistic Infections (CROI); 2018; Boston, MA. Available from: http://www.croiconference.org/sessions/ pharmacokinetics-bictegravir-administered-twice-daily-combinationrifampin. Accessed May 29, 2018.. [7484]
Custodio, West S, Vu A, et al., Pharmacokinetics of bictegravir administered twice daily with rifampin. Paper presented at: The Conference on Retroviruses and Opportunistic Infections (CROI); 2018; Boston, MA. Available from: http://www.croiconference.org/sessions/ pharmacokinetics-bictegravir-administered-twice-daily-combinationrifampin. Accessed May 29, 2018.. [7485]
Cuthbert MF. Br J Pharmacol. Oct 1971; 43(2): 471P-472P Pubmed, Volltext [2360]
Cutler AJ. CNS Spectr. Feb 2018; 23(1): 39-50 Pubmed [4906]
Cutler NR. Prog Neuropsychopharmacol Biol Psychiatry. Jan 1984; 8(2): 277-83 Pubmed [1428]
Cuzzolin L. Expert Opin Drug Metab Toxicol. Aug 2018; 14(8): 855-868 Pubmed [7824]
Cvetkovic RS. Drugs. Jan 2003; 63(8): 769-802 Pubmed [5850]
Cymbalta®,Fachinformation, Stand der Information Dez. 2012 [3594]
Cysneiros RM. Clin Pharmacol Ther. Jul 2007; 82(1): 54-62 Pubmed [2507]
Czuczwar M. Pol J Pharmacol. Sep 2003; 55(5): 799-802 Pubmed [759]
Czuczwar SJ. Expert Opin Drug Metab Toxicol. Feb 2009; 5(2): 131-6 Pubmed [9278]
Czyrak A. Arzneimittelforschung. Feb 1994; 44(2): 113-8 Pubmed [11064]
D. Schmidt, G. Eckermann, U. Fuhr, G. Luef, B.J. Steinhoff, C.E.Elger, Arzneimittelinteraktionen bei der medikamentösen Epilepsietherapie: ein kritischer Überblick, Nervenheilkunde (Nov. 2007) [2766]
D. Schmidt, G. Eckermann, U. Fuhr, G. Luef, B.J. Steinhoff, C.E.Elger. Nervenheilkunde 2007; 26(11): 969-980. Nov 2007; 26(11): 969-980 Pubmed [12553]
D. Schmidt, G. Eckermann, U. Fuhr, G. Luef, B.J. Steinhoff, C.E.Elger. Nervenheilkunde 2007; 26(11): 969-980. Nov 2007; 26(11): 969-980. Nov 0207; 26(11): 969-980 Pubmed [12554]
D'Arrigo C. Pharmacol Res. Dec 2005; 52(6): 497-501 Pubmed [2687]
D'Cunha R. Biopharm Drug Dispos. Oct 2016; 37(7): 397-408 Pubmed [7615]
D'Elia C. Urol Int. Oct 2019; : 1-6 Pubmed [8118]
D'Emanuele A. Adv Drug Deliv Rev. Dec 2005; 57(15): 2147-62 Pubmed [13033]
D'Onofrio F. Neurol Sci. May 2017; 38(Suppl 1): 117-120 Pubmed [11550]
Da Rocha et al. (2008) Rev Bras Psiquiatr 30:400-401 [2881]
Da-Rocha MA Jr. J Psychopharmacol. Jan 1997; 11(3): 211-8 Pubmed [13727]
Daali Y. Metabolism. Nov 2011; 60(11): 1584-9 Pubmed [8180]
Daar ES. Lancet HIV. Jul 2018; 5(7): e347-e356 Pubmed [7637]
Dabbert D. Reactions weekly. Jul 2012; 1411(9) Pubmed [11927]
Dabbous IA. J Pediatr. Apr 1970; 76(4): 617-20 Pubmed [9290]
Dactinomycin. Stand Jul 2022. https://www.fachinfo.de/api/fachinfo/pdf/020690 [12322]
Dahlin MG. Pediatr Neurol. Oct 2010; 43(4): 231-5 Pubmed [9520]
Dahlinger D. Ther Adv Urol. Jun 2017; 9(7): 163-177 Pubmed, Volltext, DOI [10211]
Dai CL. Biochem Pharmacol. Aug 2009; 78(4): 355-64 Pubmed, Volltext, DOI [4587]
Dai CX. Medicine (Baltimore). Sep 2018; 97(39): e12421 Pubmed [11858]
Dai H. J Pharmacol Exp Ther. Mar 2003; 304(3): 1085-92 Pubmed [4984]